GEMCITABINE, FLUDARABINE AND MELPHALAN AS A NOVEL REDUCED-INTENSITY CONDITIONING REGIMEN FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN RELAPSED AND REFRACTORY HODGKIN LYMPHOMA

類似資料

• Gemcitabine, fludarabine and melphalan for reduced-intensity conditioning and allogeneic stem cell transplantation for relapsed and refractory Hodgkin lymphoma
  著者:: Anderlini, Paolo, 等
  出版事項: (2016)
• A Randomized Phase II Trial of Fludarabine/Melphalan 100 versus Fludarabine/Melphalan 140 followed by Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma
  著者:: Bashir, Qaiser, 等
  出版事項: (2013)
• FLUDARABINE-MELPHALAN AS PREPARATIVE REGIMEN FOR REDUCED-INTENSITY ALLOGENEIC STEM CELL TRANSPLANTATION IN RELAPSED AND REFRACTORY HODGKIN’S LYMPHOMA: THE UPDATED M.D. ANDERSON CANCER CENTER EXPERIENCE
  著者:: Anderlini, Paolo, 等
  出版事項: (2008)
• Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of High-Risk Acute Myelogenous Leukemia and Myelodysplastic Syndrome Using Reduced-Intensity Conditioning with Fludarabine and Melphalan
  著者:: Oran, Betul, 等
  出版事項: (2007)
• Fludarabine, Melphalan, Thiotepa and ATG Conditioning for Unrelated Cord Blood Transplantation
  著者:: Ciurea, Stefan O., 等
  出版事項: (2012)